# EmbarkNeuro jobs and careers

> 0 open roles at EmbarkNeuro as of October 23, 2026. Source: https://www.thejobsmap.com/company/embarkneuro

EmbarkNeuro is a neuroscience-focused biotech portfolio company of Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman. EmbarkNeuro has a Phase II asset being evaluated in patients with major depressive disorder. The company was formed following the in-licensing of a selective vasopressin 1b receptor (V1b) antagonist (ANC-501) from Taisho Pharmaceutical Co., Ltd. At EmbarkNeuro, we are: patient-centric, collaborative, curious and courageous.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Oakland, CA, United States |
| Founded | 2019 |
| Employees | 1 to 10 |
| Industries | Biotechnology, Life Science, Mental Health, Therapeutics |
| Website | https://embarkneuro.com |

## Leadership

- Ellis Wilson, Vice President Clinical Operations

## Common questions

### Is EmbarkNeuro hiring right now?

EmbarkNeuro has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on EmbarkNeuro's careers site.

### Where is EmbarkNeuro headquartered?

EmbarkNeuro is headquartered in Oakland, CA, United States and was founded in 2019.

### Who leads EmbarkNeuro?

Ellis Wilson, Vice President Clinical Operations, is at the top of EmbarkNeuro's org chart.

### How do I apply for a job at EmbarkNeuro?

Pick a role on EmbarkNeuro's TheJobsMap page and select Apply. Every listing links to the original posting on EmbarkNeuro's own careers site, so you apply directly with the employer.
